Bioxcel Therapeutics Inc

CUSIP 09075P204COM NEWBTAIQ1 2026

13D / 13G Filings

Schedule 13D/13G on record

Beneficial Filers

Distinct reporting persons

Largest Stake

11.0%

Max % of class reported

Institutional Holders

13F filers (latest quarter)

4 filings · latest Feb 9, 2026

#	Filed	Reporting Person	Form	% of Class	Shares	Filing
1	Feb 9, 2026	Integrated Core Strategies (Us) LLC	13G/A	11.0%	1.84M	SEC
2	Oct 1, 2025	Integrated Core Strategies (Us) LLC	13G	11.0%	1.03M	SEC
3	May 15, 2025	Armistice Capital, LLC	13G/A	5.0%	288.1K	SEC
4	Feb 14, 2025	Armistice Capital, LLC	13G	10.0%	5.00M	SEC

Largest reported positions · latest quarter

#	Fund	Shares	Value
1	Millennium Management LLC	1.94M	$2.60M
2	Armistice Capital, LLC	1.91M	$2.56M
3	Oaktree Capital Management LP	241.2K	$323.2K
4	Geode Capital Management, LLC	230.2K	$308.7K
5	Jones Financial Companies Lllp	131.8K	$166.1K
6	Man Group PLC	96.5K	$129.3K
7	State Street Corp	92.1K	$123.4K
8	Fmr LLC	90.3K	$121.0K
9	Blackrock, Inc.	84.3K	$112.9K
10	&Partners	80.9K	$108.4K